based custom software package: conn Search Results


semi-automatic design software siemens nx 10  (Siemens AG)
90
Siemens AG semi-automatic design software siemens nx 10
Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.
Semi Automatic Design Software Siemens Nx 10, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/nx+10+0+software/pmc10305231-3-0-6
Average 90 stars, based on 1 article reviews
semi-automatic design software siemens nx 10 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
igor pro 7.01 software  (wavemetrics inc)
90
wavemetrics inc igor pro 7.01 software
Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.
Igor Pro 7.01 Software, supplied by wavemetrics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/igor+pro+8/10__3389_slash_fncel__2022__920075-91-13-18
Average 90 stars, based on 1 article reviews
igor pro 7.01 software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
computer database filemaker pro 7.0  (FileMaker Inc)
90
FileMaker Inc computer database filemaker pro 7.0
Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.
Computer Database Filemaker Pro 7.0, supplied by FileMaker Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/filemaker+pro+7/pm20440918-44-4-11
Average 90 stars, based on 1 article reviews
computer database filemaker pro 7.0 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
custom matlab software package  (MathWorks Inc)
93
MathWorks Inc custom matlab software package
Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.
Custom Matlab Software Package, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/MATLAB+Parallel+Server/fok_alice__2019__curiouser_and_curiouser_non_canonical_modulators_of_bioaminergic_and_mechanosensory_systems-266-7-8
Average 93 stars, based on 1 article reviews
custom matlab software package - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
pv-wave  (Visual Numerics Inc)
90
Visual Numerics Inc pv-wave
Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.
Pv Wave, supplied by Visual Numerics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/pv+wave/pmc07004280-177-10-19
Average 90 stars, based on 1 article reviews
pv-wave - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
custom exported excel-based software  (Quanteon LLC)
90
Quanteon LLC custom exported excel-based software
Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.
Custom Exported Excel Based Software, supplied by Quanteon LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/custom+exported+excel+tm+++based+software/pmc03375214-126-10-12
Average 90 stars, based on 1 article reviews
custom exported excel-based software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human biomarker custom premix kit  (R&D Systems)
90
R&D Systems human biomarker custom premix kit
FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each <t>biomarker,</t> adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.
Human Biomarker Custom Premix Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/Human+Biomarker+Panel+A+Luminex%C2%AE+Performance+Control/10__1097_slash_qai__0000000000001261-61-47-53
Average 90 stars, based on 1 article reviews
human biomarker custom premix kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdna production  (Worthington Biochemical)
99
Worthington Biochemical cdna production
FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each <t>biomarker,</t> adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.
Cdna Production, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/Papain+Dissociation+System/pm33548171-268-95-117
Average 99 stars, based on 1 article reviews
cdna production - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
custom bitflow sdk based software  (BitFlow Inc)
90
BitFlow Inc custom bitflow sdk based software
FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each <t>biomarker,</t> adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.
Custom Bitflow Sdk Based Software, supplied by BitFlow Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/custom+bitflow+sdk+based+software/pmc03003684-185-13-14
Average 90 stars, based on 1 article reviews
custom bitflow sdk based software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
digital pressure sensor omega engineering  (OMEGA Engineering)
90
OMEGA Engineering digital pressure sensor omega engineering
FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each <t>biomarker,</t> adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.
Digital Pressure Sensor Omega Engineering, supplied by OMEGA Engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/thermometer/pmc04312031-49-12-15
Average 90 stars, based on 1 article reviews
digital pressure sensor omega engineering - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
custom software based subroutines (nic-2  (Cochlear Limited)
90
Cochlear Limited custom software based subroutines (nic-2
FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each <t>biomarker,</t> adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.
Custom Software Based Subroutines (Nic 2, supplied by Cochlear Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/custom+software+based+subroutines++nic+2/pmc03376347-136-11-15
Average 90 stars, based on 1 article reviews
custom software based subroutines (nic-2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
igorpro software  (wavemetrics inc)
90
wavemetrics inc igorpro software
FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each <t>biomarker,</t> adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.
Igorpro Software, supplied by wavemetrics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/based+custom+software+package%3A+conn/igor+pro+software/pmc02290414-54-13-15
Average 90 stars, based on 1 article reviews
igorpro software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.

Journal: Polymers

Article Title: Investigations on the Fatigue Behavior of 3D-Printed and Thermoformed Polylactic Acid Wrist–Hand Orthoses

doi: 10.3390/polym15122737

Figure Lengend Snippet: Summary of the studies on 3DP-WHOs’ mechanical testing and FE simulations.

Article Snippet: Customized semi-automatic design software based on Siemens NX 10; 2 parts WHO with zip ties; different designs for the ventilation holes (circular holes, Voronoi, topology optimization).

Techniques: Comparison, Software, Injection

FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each biomarker, adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.

Journal: JAIDS Journal of Acquired Immune Deficiency Syndromes

Article Title: Frailty and Circulating Markers of Inflammation in HIV+ and HIV− Men in the Multicenter AIDS Cohort Study

doi: 10.1097/qai.0000000000001261

Figure Lengend Snippet: FIGURE 2. Relative percentile estimates for the HIV2 frail group, the HIV+ nonfrail group, and the HIV+ frail group (left, middle, and right d, respectively), and 95% confidence limits of the estimates (error bars), for exposure groups relative to the nonfrail HIV2 group, obtained by generalized gamma regression models for each biomarker, adjusted for age, race, study sites, and education, and BMI, current smoking, depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer. Significant differences (P # 0.002) are indicated by #. Marginally significant differences (0.002 , P , 0.05) are those for which the 95% confidence intervals do not include 1.0. Relative percentile estimates are given for differences that were significant or marginally significant. The biomarkers that had $1 significant (P , 0.05) comparison in any analysis are shown.

Article Snippet: Serum levels of soluble (s) CD14, sCD27, sgp130, sIL6 receptor (sIL-6R), sIL-2 receptor-a (sCD25), and sTNF receptor-2 (sTNFR2), plus a cytokine known as B-cellactivating factor or B-lymphocyte stimulator (BAFF/BLyS), and the chemokine CXCL13 (B-lymphocyte chemoattractant/ B-cell-attracting chemokine 1; BLC/BCA1) were measured in one custom-designed multiplexed assay panel (Human Biomarker Custom Premix Kit A, R & D Systems, Minneapolis, MN) per manufacturer’s directions at the University of California, Los Angeles, using a Bio-Plex 200 Luminex instrument and Bio-Plex analysis software (Bio-Rad, Hercules, CA).

Techniques: Biomarker Discovery, Infection, Comparison

FIGURE 3. Relative percentile estimates (d) and 95% confidence limits (error bars) of the estimates for the frail HIV+ men compared with nonfrail HIV+ men. Data were generated using generalized gamma regression models for each biomarker adjusted for age, race, study sites, and education (left bars with d, model 1) and further adjusted for BMI, current smoking, presence of depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer (right bars with d, model 2). Relative percentile differences between the frail and nonfrail HIV+ men that were significantly different at P # 0.002 are indicated by #; those that were significantly different at 0.002 # P #0.05 are those for which the 95% confidence intervals do not include 1.0.

Journal: JAIDS Journal of Acquired Immune Deficiency Syndromes

Article Title: Frailty and Circulating Markers of Inflammation in HIV+ and HIV− Men in the Multicenter AIDS Cohort Study

doi: 10.1097/qai.0000000000001261

Figure Lengend Snippet: FIGURE 3. Relative percentile estimates (d) and 95% confidence limits (error bars) of the estimates for the frail HIV+ men compared with nonfrail HIV+ men. Data were generated using generalized gamma regression models for each biomarker adjusted for age, race, study sites, and education (left bars with d, model 1) and further adjusted for BMI, current smoking, presence of depressive symptoms, HCV infection, hypertension, diabetes, dyslipidemia, kidney disease, liver disease, and cancer (right bars with d, model 2). Relative percentile differences between the frail and nonfrail HIV+ men that were significantly different at P # 0.002 are indicated by #; those that were significantly different at 0.002 # P #0.05 are those for which the 95% confidence intervals do not include 1.0.

Article Snippet: Serum levels of soluble (s) CD14, sCD27, sgp130, sIL6 receptor (sIL-6R), sIL-2 receptor-a (sCD25), and sTNF receptor-2 (sTNFR2), plus a cytokine known as B-cellactivating factor or B-lymphocyte stimulator (BAFF/BLyS), and the chemokine CXCL13 (B-lymphocyte chemoattractant/ B-cell-attracting chemokine 1; BLC/BCA1) were measured in one custom-designed multiplexed assay panel (Human Biomarker Custom Premix Kit A, R & D Systems, Minneapolis, MN) per manufacturer’s directions at the University of California, Los Angeles, using a Bio-Plex 200 Luminex instrument and Bio-Plex analysis software (Bio-Rad, Hercules, CA).

Techniques: Generated, Biomarker Discovery, Infection